Correction of technical issuing details of the final terms in the rights issue
CORRECTION: STOCKHOLM, 7 August 2023. Due to technical issuing details at Euroclear Sweden AB, a correction has been made in relation to the final terms published on 4 August 2023, with a change regarding the number of unit rights shareholders are allocated per existing ordinary share and the number of units the unit rights entitle to. The correction does not affect the subscription price or transaction size.Existing shareholders in Moberg Pharma as of the record date, 14 August 2023, will receive sixteen (16) (previously communicated eight (8)) unit rights per one (1) existing ordinary